AG˹ٷ

STOCK TITAN

[Form 4] IBEX Limited Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

IBEX Ltd director and Chief People Officer Paul Joseph Inson reported a sale of 10,000 common shares on 08/22/2025. The shares were sold in multiple trades at prices ranging from $30.00 to $30.13, with a weighted average sale price reported as $30.0013. After the sale, the reporting person beneficially owned 7,352 shares directly. The filing also indicates the transaction was made pursuant to a prearranged plan intended to satisfy Rule 10b5-1(c), and the filer offers to provide trade-by-trade pricing details upon request.

Il direttore e Chief People Officer di IBEX Ltd, Paul Joseph Inson, ha dichiarato la vendita di 10.000 azioni ordinarie il 22/08/2025. Le azioni sono state vendute in più operazioni a prezzi compresi tra $30,00 e $30,13, con un prezzo medio ponderato di vendita riportato pari a $30,0013. Dopo la vendita, la persona che ha presentato la dichiarazione deteneva direttamente 7.352 azioni. Il deposito indica inoltre che la transazione è stata eseguita ai sensi di un piano predefinito volto a soddisfare la Regola 10b5-1(c) e che il dichiarante è disponibile a fornire i dettagli prezzo per prezzo delle singole operazioni su richiesta.

Paul Joseph Inson, director y Chief People Officer de IBEX Ltd, informó la venta de 10.000 acciones comunes el 22/08/2025. Las acciones se vendieron en múltiples operaciones a precios que oscilaron entre $30.00 y $30.13, con un precio medio ponderado de venta declarado de $30.0013. Tras la venta, la persona informante poseía directamente 7.352 acciones. El informe también indica que la operación se realizó en virtud de un plan preestablecido destinado a cumplir con la Regla 10b5-1(c) y que el declarante ofrece proporcionar los precios de cada operación por separado a petición.

IBEX Ltd� 이사 � 최고인사책임�(Chief People Officer)� Paul Joseph Inson은 2025-08-2210,000 보통�� 매도했다� 신고했습니다. 해당 주식은 여러 차례 거래� $30.00에서 $30.13 사이� 가격에 매도되었으며, 보고� 가중평� 매도가� $30.0013입니�. 매도 � 보고자는 직접적으� 7,352�� 보유하고 있었습니�. 제출서류� 또한 � 거래가 Rule 10b5-1(c)� 충족하기 위한 사전약정 계획� 따라 이루어졌음을 나타내며, 신고인은 요청 � 거래� 가� 세부정보� 제공하겠다고 밝혔습니�.

Paul Joseph Inson, administrateur et Chief People Officer d'IBEX Ltd, a déclaré la vente de 10 000 actions ordinaires le 22/08/2025. Les actions ont été vendues en plusieurs opérations à des prix allant de $30,00 à $30,13, avec un prix de vente moyen pondéré déclaré de $30,0013. Après la vente, la personne déclarante détenait directement 7 352 actions. Le dossier indique également que la transaction a été effectuée en vertu d'un plan préétabli destiné à satisfaire la règle 10b5-1(c), et le déclarant propose de fournir, sur demande, les détails des prix pour chaque transaction.

Paul Joseph Inson, Direktor und Chief People Officer von IBEX Ltd, meldete den Verkauf von 10.000 Stammaktien am 22.08.2025. Die Aktien wurden in mehreren Trades zu Preisen zwischen $30,00 und $30,13 verkauft; der angegebene gewichtete Durchschnittspreis beträgt $30,0013. Nach dem Verkauf besaß die meldende Person direkt 7.352 Aktien. Die Meldung gibt außerdem an, dass die Transaktion im Rahmen eines vorgeplanten Plans zur Erfüllung von Regel 10b5-1(c) erfolgte, und der Melder bietet an, auf Anfrage die Einzeltrade-Preise mitzuteilen.

Positive
  • Transaction executed under a Rule 10b5-1 plan, indicating trades were prearranged and may reduce concerns about trading on material nonpublic information
  • Filer disclosed price range ($30.00�$30.13) and offered to provide per-trade details, increasing transparency
Negative
  • Insider sale of 10,000 shares reduced direct beneficial ownership to 7,352 shares, which could be viewed negatively by some investors absent further context

Insights

TL;DR: An officer sold a modest block of shares under a 10b5-1 plan; this is routine disclosure, not an immediate alarm.

The sale of 10,000 shares by the Chief People Officer at ~$30 per share reduced direct holdings to 7,352 shares. The filing checks the box indicating the use of a Rule 10b5-1 plan, which typically signals the trades were preplanned and may mitigate concerns about contemporaneous insider knowledge. The disclosure includes an offer to provide per-trade pricing details, enhancing transparency. Absent additional context on company size or percentage ownership change, this appears to be a standard insider disposition rather than a material corporate development.

TL;DR: Proper Form 4 mechanics were followed; use of 10b5-1 and explicit pricing range improves compliance visibility.

The report identifies the reporting person, role, and address, and includes the required signed certification by an attorney-in-fact. Notably, the filer disclosed the trade price range and committed to provide per-trade details if requested, which supports governance best practices for transparency. The filing does not state whether the sale was motivated by personal diversification, tax planning, or other reasons, so governance implications are limited to procedural compliance rather than stewardship concerns.

Il direttore e Chief People Officer di IBEX Ltd, Paul Joseph Inson, ha dichiarato la vendita di 10.000 azioni ordinarie il 22/08/2025. Le azioni sono state vendute in più operazioni a prezzi compresi tra $30,00 e $30,13, con un prezzo medio ponderato di vendita riportato pari a $30,0013. Dopo la vendita, la persona che ha presentato la dichiarazione deteneva direttamente 7.352 azioni. Il deposito indica inoltre che la transazione è stata eseguita ai sensi di un piano predefinito volto a soddisfare la Regola 10b5-1(c) e che il dichiarante è disponibile a fornire i dettagli prezzo per prezzo delle singole operazioni su richiesta.

Paul Joseph Inson, director y Chief People Officer de IBEX Ltd, informó la venta de 10.000 acciones comunes el 22/08/2025. Las acciones se vendieron en múltiples operaciones a precios que oscilaron entre $30.00 y $30.13, con un precio medio ponderado de venta declarado de $30.0013. Tras la venta, la persona informante poseía directamente 7.352 acciones. El informe también indica que la operación se realizó en virtud de un plan preestablecido destinado a cumplir con la Regla 10b5-1(c) y que el declarante ofrece proporcionar los precios de cada operación por separado a petición.

IBEX Ltd� 이사 � 최고인사책임�(Chief People Officer)� Paul Joseph Inson은 2025-08-2210,000 보통�� 매도했다� 신고했습니다. 해당 주식은 여러 차례 거래� $30.00에서 $30.13 사이� 가격에 매도되었으며, 보고� 가중평� 매도가� $30.0013입니�. 매도 � 보고자는 직접적으� 7,352�� 보유하고 있었습니�. 제출서류� 또한 � 거래가 Rule 10b5-1(c)� 충족하기 위한 사전약정 계획� 따라 이루어졌음을 나타내며, 신고인은 요청 � 거래� 가� 세부정보� 제공하겠다고 밝혔습니�.

Paul Joseph Inson, administrateur et Chief People Officer d'IBEX Ltd, a déclaré la vente de 10 000 actions ordinaires le 22/08/2025. Les actions ont été vendues en plusieurs opérations à des prix allant de $30,00 à $30,13, avec un prix de vente moyen pondéré déclaré de $30,0013. Après la vente, la personne déclarante détenait directement 7 352 actions. Le dossier indique également que la transaction a été effectuée en vertu d'un plan préétabli destiné à satisfaire la règle 10b5-1(c), et le déclarant propose de fournir, sur demande, les détails des prix pour chaque transaction.

Paul Joseph Inson, Direktor und Chief People Officer von IBEX Ltd, meldete den Verkauf von 10.000 Stammaktien am 22.08.2025. Die Aktien wurden in mehreren Trades zu Preisen zwischen $30,00 und $30,13 verkauft; der angegebene gewichtete Durchschnittspreis beträgt $30,0013. Nach dem Verkauf besaß die meldende Person direkt 7.352 Aktien. Die Meldung gibt außerdem an, dass die Transaktion im Rahmen eines vorgeplanten Plans zur Erfüllung von Regel 10b5-1(c) erfolgte, und der Melder bietet an, auf Anfrage die Einzeltrade-Preise mitzuteilen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Inson Paul Joseph

(Last) (First) (Middle)
C/O IBEX LIMITED
1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)
WASHINGTON DC 20006

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief People Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 08/22/2025 S 10,000 D $30.0013(1) 7,352 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $30.00 to $30.13; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Remarks:
Lisa Lenstrohm, Attorney-in-Fact 08/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the IBEX (IBEX) Form 4 filed by Paul Joseph Inson report?

The Form 4 reports a sale of 10,000 common shares on 08/22/2025 executed in multiple trades at prices between $30.00 and $30.13, leaving the reporting person with 7,352 shares.

Was the sale by the IBEX officer part of a 10b5-1 trading plan?

Yes. The filing indicates the transaction was made pursuant to a plan intended to satisfy Rule 10b5-1(c).

What price was reported for the shares sold in the IBEX Form 4?

The weighted average sale price reported is $30.0013, with individual trade prices ranging from $30.00 to $30.13.

How many shares does the reporting person own after the transaction?

7,352 common shares are reported as beneficially owned following the sale.

Who signed the Form 4 for the reporting person?

Lisa Lenstrohm, Attorney-in-Fact signed the Form 4 on behalf of the reporting person on 08/22/2025.
Ibex Ltd

NASDAQ:IBEX

IBEX Rankings

IBEX Latest News

IBEX Latest SEC Filings

IBEX Stock Data

390.34M
11.60M
13.05%
94.41%
1.3%
Information Technology Services
Services-computer Processing & Data Preparation
United States
WASHINGTON